In this prospective, observational study, patient data (eg, clinical outcomes in actual
clinical settings, demographic information, medical treatment-related information, Mevalotin®
Tablet administration start date [Index date], and the lipid profile results at Week 24 after
Mevalotin® Tablet administration start date) will be collected from medical records. No study
drug will be administered in this study.
Patient data will be used to determine the change in blood cholesterol with Mevalotin® Tablet
administration (5 mg, 10 mg, 20 mg, 40 mg as determined by Investigator in clinical practice)
in Korean menopausal women aged 50 years or more who require treatment of dyslipidemia.
How understandable was the trial content above?
Hard to understand
Easy to understand